Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...
Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback